Clinical Trials Browser

Phase 1 × sintilimab × Tumor-Agnostic × Clear all

NCT07455617 2026-03-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

Phase 1 Not yet recruiting

Neoplasm Metastasis